How many tablets of entrectinib should be taken daily? What is the specific dosage and method of taking it?

Entrectinib (Entrectinib) is a multi-target oral targeted drug that is widely used to treat patients with NTRK fusion or ROS1 fusion non-small cell lung cancer and solid tumors. Its administration method has clear regulations. According to the drug information, the recommended dose of the drug is mainly adjusted based on the patient's weight and age. In adults or adolescents, the standard recommended dose is 600 mg taken orally once daily, usually in the form of six 100 mg capsules. Therefore, most adult patients need to take 6 tablets of entrectinib daily, and it is recommended to swallow it at one time to maintain a stable blood concentration.

It is best to take the medicine at a fixed time every day. It is recommended to take it within the same time period. It can be taken with food or on an empty stomach. However, it is necessary to avoid taking it at the same time with high-fat meals to reduce absorption interference. Entrectinib capsules cannot be broken, crushed or dissolved and must be swallowed whole to ensure that their release mechanism in the body is not destroyed. If you miss a dose due to special reasons, you can take it in time if it is more than 12 hours before the next dose. If it is less than 12 hours, it is recommended to skip it to avoid repeated medication. For pediatric patients weighing less than 20 kilograms, the dosage should be individually adjusted by the doctor according to the specific weight, rather than simply following the adult dosage. This is also a prerequisite to ensure safety and efficacy.

In addition, patients should pay attention to drug interactions while using entrectinib, especially avoid concurrent use with strongCYP3A4 enzyme inhibitors or inducers, as this may affect the metabolism of entrectinib in the body, thereby affecting the efficacy or increasing the risk of toxicity. During treatment, doctors may make dose adjustments based on patient tolerance. For example, the dose may be reduced to 400 mg or lower when severe adverse reactions occur. This individualized management is the key to long-term treatment success.

Reference materials:https://www.roche.com/products/rozlytrek